Download antimicrobial use

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Pharmacokinetics wikipedia, lookup

Theralizumab wikipedia, lookup

Bilastine wikipedia, lookup

Prescription costs wikipedia, lookup

Pharmacogenomics wikipedia, lookup

Bad Pharma wikipedia, lookup

Adherence (medicine) wikipedia, lookup

Psychedelic therapy wikipedia, lookup

Vancomycin wikipedia, lookup

Dydrogesterone wikipedia, lookup

Ciprofloxacin wikipedia, lookup

Transcript
K. References
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
Bliziotis IA, Plessa E, Pappas G, Falagas ME. Daptomycin versus other antimicrobial
agents for the treatment of skin and soft tissue infections: A meta-analysis. Annals
Pharmacother 2010;44:97-106.
Fowler VG, Boucher HW, Corey RG, Abrutyn E, Karchmer AW, Rupp ME, Levine DP,
Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M,
Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M,
Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study
Group. Daptomycin vs. standard therapy for bacteremia and endocarditis caused by
Staphylococcus aureus. N Engl J Med 2006;355 653-65
Mohr JF, Friedrich LV, Yankelev S, Lamp KC. Daptomycin for the treatment of
enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience
(CORE). Int J Antimicrob Agents 2009;33:543-548.
Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG. Cost-effectiveness of daptomycin
versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus
aureus bacteremia or endocarditis. Clin Infect Dis 2009;49:691-698.
Bhavnani SM, Rubino CM, Ambrose PG, Drusano GL. Daptomycin exposure and the
probability of elevations in the creatine phosphokinase level: Data from a randomized trial of
patients with bacteremia and endocarditis. Clin Infect Dis 2010;50:1568-1574.
Salama NN, Segal JH, Churchwell MD, et al. Single-dose daptomycin pharmacokinetics in
chronic haemodialysis patients. Nephrol Dial Transplant 2010;25:1279-1284.
Salama NN, Segal JH, Churchwell MD, et al. Intradialytic administration of daptomycin in
end stage renal disease patients on hemodialysis. Clin J Am Soc Nephrol. 2009;4:11901194.
Vilay AM, Brio M, DePestel DD, et al. Daptomycin pharmacokinetics in critically ill patients
receiving continous venovenous hemodialysis. Crit Care Med. 2011;39:19-25.